Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
Resources Genes Glycoproteins Lectins Glycolipids Glycans Pathways Diseases Organisms
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
Other Information
Release Statistics Download
Tools
SugarDrawer GlycanBuilder Glycan Converters GlycoMaple GlycomeAtlas LM-GlycomeAtlas GALAXY MCAW GlycoSim GRable
Search Tools
Cross Search Glycan Search Publication Search Programmatic Access
Standards Ontologies Notations
eye disease

Summary
Definition
An eye and adnexa disease that is located_in the eye.
Super Class
sensory system disease
External Links
Disease Ontology
DOID:5614
Mondo Disease Ontology
MeSH
UMLS
NCI Thesaurus
Related Genes
Displaying entries 31 - 34 of 34 in total
Gene ID Gene Symbol Description Source
93589 CACNA2D4 calcium voltage-gated channel auxiliary subunit alpha2delta 4
145173 B3GLCT beta 3-glucosyltransferase
158326 FREM1 FRAS1 related extracellular matrix 1
340075 ARSI arylsulfatase family member I
Displaying all 3 entries
Gene ID Gene Symbol Description Source
21898 Tlr4 toll-like receptor 4
21926 Tnf tumor necrosis factor
24088 Tlr2 toll-like receptor 2
Displaying all 2 entries
Gene ID Gene Symbol Description Source
24835 Tnf tumor necrosis factor
29260 Tlr4 toll-like receptor 4
Displaying 1 entry
Gene ID Gene Symbol Description Source
43222 Tl Toll
Related Glycoprotein
About Release Notes Help Feedback
International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01

Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International

GlyCosmos Portal v4.0.0

Last updated: August 19, 2024